The investigational product BCD-236 is a full-length monoclonal antibody.
A monoclonal antibody is a protein created by scientists in the laboratory, which is equivalent to natural immune system antibodies and designed to bind to a specific target in the human body1. BCD-236 is one of the medicinal products in BIOCAD’s clinical development program.
- Weiner LM, Surana R., Wang S. Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nature Reviews Immunology. 2010;10(5):317–27.
This section of the website contains information about an unauthorized investigational medicinal product for medical use.